News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
430,942 Results
Type
Article (27076)
Company Profile (123)
Press Release (403743)
Section
Business (128421)
Career Advice (887)
Deals (22297)
Drug Delivery (87)
Drug Development (60322)
Employer Resources (74)
FDA (10610)
Job Trends (9462)
News (225688)
Policy (21873)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (3)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1777)
Adcomms (14)
Allergies (46)
Alliances (32527)
ALS (61)
Alzheimer's disease (1024)
Antibody-drug conjugate (ADC) (70)
Approvals (10642)
Artificial intelligence (137)
Autoimmune disease (7)
Automation (9)
Bankruptcy (203)
Best Places to Work (7317)
BIOSECURE Act (20)
Biosimilars (59)
Biotechnology (57)
Bladder cancer (37)
Brain cancer (19)
Breast cancer (157)
Cancer (1185)
Cardiovascular disease (109)
Career advice (747)
Career pathing (18)
CAR-T (78)
Cell therapy (221)
Cervical cancer (9)
Clinical research (49068)
Collaboration (454)
Compensation (189)
Complete response letters (18)
COVID-19 (1663)
CRISPR (25)
C-suite (123)
Cystic fibrosis (70)
Data (1271)
Denatured (16)
Depression (17)
Diabetes (167)
Diagnostics (3365)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (23)
Drug discovery (78)
Drug pricing (73)
Drug shortages (23)
Duchenne muscular dystrophy (42)
Earnings (50570)
Editorial (16)
Employer branding (5)
Employer resources (66)
Events (62966)
Executive appointments (409)
FDA (11274)
Featured Employer (28)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (359)
Gene editing (62)
Generative AI (12)
Gene therapy (213)
GLP-1 (523)
Government (2824)
Grass and pollen (2)
Guidances (32)
Healthcare (10399)
Huntington's disease (10)
IgA nephropathy (20)
Immunology and inflammation (49)
Indications (18)
Infectious disease (1738)
Inflammatory bowel disease (77)
Inflation Reduction Act (7)
Influenza (26)
Intellectual property (48)
Interviews (122)
IPO (9751)
IRA (35)
Job creations (2483)
Job search strategy (678)
Kidney cancer (7)
Labor market (12)
Layoffs (263)
Leadership (8)
Legal (4797)
Liver cancer (43)
Lung cancer (182)
Lymphoma (91)
Machine learning (1)
Management (25)
Manufacturing (187)
MASH (62)
Medical device (6089)
Medtech (6092)
Mergers & acquisitions (12794)
Metabolic disorders (444)
Multiple sclerosis (42)
NASH (22)
Neurodegenerative disease (51)
Neuropsychiatric disorders (11)
Neuroscience (1330)
NextGen: Class of 2025 (3416)
Non-profit (2326)
Northern California (1316)
Now hiring (29)
Obesity (230)
Opinion (155)
Ovarian cancer (39)
Pain (65)
Pancreatic cancer (42)
Parkinson's disease (79)
Partnered (8)
Patents (123)
Patient recruitment (58)
Peanut (22)
People (38748)
Pharmaceutical (68)
Pharmacy benefit managers (11)
Phase I (14304)
Phase II (21636)
Phase III (17001)
Pipeline (592)
Podcasts (61)
Policy (86)
Postmarket research (1968)
Preclinical (6225)
Press Release (62)
Prostate cancer (61)
Psychedelics (14)
Radiopharmaceuticals (172)
Rare diseases (245)
Real estate (3605)
Recruiting (26)
Regulatory (15528)
Reports (16)
Research institute (1445)
Resumes & cover letters (129)
Rett syndrome (2)
RSV (21)
Schizophrenia (51)
Series A (63)
Series B (31)
Service/supplier (4)
Sickle cell disease (38)
Southern California (1177)
Special edition (6)
Sponsored (16)
Startups (2253)
State (2)
Stomach cancer (6)
Supply chain (37)
The Weekly (44)
United States (11754)
Vaccines (327)
Venture capitalists (17)
Webinars (10)
Weight loss (152)
Women's health (11)
Worklife (5)
Date
Today (130)
Last 7 days (539)
Last 30 days (1901)
Last 365 days (22533)
2025 (3593)
2024 (22945)
2023 (25960)
2022 (34209)
2021 (36082)
2020 (34005)
2019 (27798)
2018 (21462)
2017 (21922)
2016 (20941)
2015 (24743)
2014 (19069)
2013 (15769)
2012 (16930)
2011 (17545)
2010 (15721)
Location
Africa (466)
Alabama (23)
Alaska (1)
Arizona (82)
Arkansas (6)
Asia (33604)
Australia (4270)
California (2961)
Canada (1131)
China (432)
Colorado (129)
Connecticut (136)
Delaware (67)
Europe (58417)
Florida (447)
Georgia (99)
Idaho (24)
Illinois (273)
India (14)
Indiana (167)
Iowa (2)
Japan (110)
Kansas (64)
Kentucky (15)
Louisiana (5)
Maine (31)
Maryland (465)
Massachusetts (2289)
Michigan (89)
Minnesota (165)
Missouri (37)
Montana (17)
Nebraska (13)
Nevada (25)
New Hampshire (37)
New Jersey (1050)
New Mexico (9)
New York (942)
North Carolina (578)
North Dakota (5)
Northern California (1316)
Ohio (106)
Oklahoma (5)
Oregon (24)
Pennsylvania (691)
Puerto Rico (7)
Rhode Island (6)
South America (742)
South Carolina (6)
South Dakota (1)
Southern California (1177)
Tennessee (62)
Texas (401)
Utah (85)
Virginia (96)
Washington D.C. (39)
Washington State (297)
West Virginia (2)
Wisconsin (20)
430,942 Results for "china pharmaceutical association cpa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
AstraZeneca Buys FibroGen’s China Unit for $160M as Probes Continue
A year ago, AstraZeneca walked away from the bulk of its roxadustat partnership with FibroGen—though the pharma at the time decided to retain its relationship with the biotech’s China operations.
February 20, 2025
·
2 min read
·
Tristan Manalac
China
The Rise of China Innovation in the Time of Trump
With incoming president Donald Trump threatening a trade war with China, experts told
BioSpace
that the new administration will likely understand why medicines should be treated differently.
January 16, 2025
·
4 min read
·
Annalee Armstrong
Earnings
Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing
With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as bringing assets over from China.
February 4, 2025
·
4 min read
·
Annalee Armstrong
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Earnings
Merck’s Gardasil Woes Grow as China Trade War Heats Up
Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.
February 4, 2025
·
4 min read
·
Annalee Armstrong
Business
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer
Centessa Pharmaceuticals plc announced that John Crowley CPA, has been appointed Chief Financial Officer, and Gregory Weinhoff MD MBA, former Chief Financial Officer, has been appointed to the newly created role of Chief Business Officer, effective June 10, 2024.
June 10, 2024
·
6 min read
Antibody drug conjugate
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.
January 2, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
ITF Therapeutics LLC Announces Appointment of Erica L. Monaco, CPA, as Chief Operating Officer
December 4, 2024
·
7 min read
Press Releases
Tenapanor Approved in China for Hyperphosphatemia
February 26, 2025
·
5 min read
Biotech Beach
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
Gyre Therapeutics today announced that the Center for Drug Evaluation (“CDE”) of China’s National Medical Products Administration (“NMPA”) has approved Gyre Pharmaceuticals’ (Gyre’s indirectly controlled subsidiary) Investigational New Drug (“IND”) application for F230 tablets.
May 30, 2024
·
3 min read
1 of 43,095
Next
